Intersect ENT Reports Preliminary Q4 And Year 2015 Revenue
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported preliminary revenue for the fourth quarter and year ended December 31, 2015.
•Fourth quarter revenue of approximately $18.6 to $18.8 million, up approximately 40% over the fourth quarter of 2014
•Fourth quarter revenue of approximately $18.6 to $18.8 million, up approximately 40% over the fourth quarter of 2014